|
AFMD
|
Affimed Therapeutics B.V.
|
US
|
NASDAQ
|
|
CCXI
|
ChemoCentryx, Inc.
|
US
|
NASDAQ
|
|
CLDX
|
Celldex Therapeutics, Inc.
|
US
|
NASDAQ
|
|
CLLS
|
Cellectis S.A.
|
US
|
NASDAQ
|
|
CLRB
|
Cellectar Biosciences, Inc.
|
US
|
NASDAQ
|
|
CNSP
|
CNS Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
DCPH
|
Deciphera Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
DFFN
|
Diffusion Pharmaceuticals Inc.
|
US
|
NASDAQ
|
|
GNTA
|
Genenta Science S.p.A.
|
US
|
NASDAQ
|
|
MBRX
|
Moleculin Biotech, Inc.
|
US
|
NASDAQ
|
|
NVCR
|
NovoCure Limited
|
US
|
NASDAQ
|
|
PRLD
|
Prelude Therapeutics Incorporated
|
US
|
NASDAQ
|
|
PSTV
|
Plus Therapeutics, Inc.
|
US
|
NASDAQ
|
|
RGLS
|
Regulus Therapeutics Inc.
|
US
|
NASDAQ
|
|
SGMO
|
Sangamo BioSciences, Inc.
|
US
|
NASDAQ
|
|
TCON
|
TRACON Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
VBLT
|
Vascular Biogenics Ltd.
|
US
|
NASDAQ
|
|
CHM
|
Chimeric Therapeutics Limited NL
|
AU
|
ASX
|
|
TLX
|
Telix Pharmaceuticals Ltd
|
AU
|
ASX
|
|
DMPWW
|
Delmar Pharmaceuticals Inc - Warrants [16/08/202
|
US
|
OTC
|